Main Products/ Services/ Pipelines & Platforms
Ever Supreme’s CAR001 and INSP003 are innovative cancer therapies. CAR001, a multi-targeting CAR-T therapy, aiming HLA-G and PD-L1, currently enrolling Phase I/IIa trials. INSP003, nano-particle delivering Docetaxel via Fucoidan encapsulation for precise targeting.
Ever Supreme, a CDMO, offers customized cell & regenerative medicine services across three specialized facilities, supporting clinical & commercial manufacturing while advancing global partnerships for innovative treatments.
Ever Supreme's four platforms—immune cells, stem cells, nanoparticles, and exosomes—drive innovative therapies for oncology & regenerative medicine, advancing precision treatments for solid tumors & critical diseases.
Business Interests
Out-Licensing, CDMO, Clinical Trial Collaboration
Contact Info
Sammi, Hsu
Director, Business Development
+886-4-2325-2888 #521
cthsu@ever-supreme.com.tw